Japan's Kaketsuken covered up illicit blood product, vaccine production methods for 40 years

A whistleblower has tipped off Japanese authorities that Chemo-Sero-Therapeutic Research Institute (Kaketsuken), a manufacturer of blood products and vaccines, has been adding unauthorized ingredients to its products and falsifying data. An investigative panel found that the institute has been doing so for more than 40 years. Earlier this year, Kaketsuken signed a deal with Takeda and Daiichi Sankyo for the latter companies to distribute its seasonal flu shots alongside their own. Read more from FiercePharmaAsia

Suggested Articles

The FDA is evaluating the possibility of prosecuting those involved in rogue herpes vaccine research led by a Southern Illinois University professor.

New legal complaints focus on eight Sanofi executives, most of them with local management titles, and 15 managers at distributor Zuellig Pharma.

Experts say technology is advancing to develop vaccines faster at a time of increasing emerging disease outbreaks.